| 18F-FDG PET/18F-FDG PET | 57 |
| 18F-FDG PET/CT scans/18F-FDG PET/BT taramaları | 86 |
| 18F-FDG PET/CT/18F-FDG PET/BT | 18, 47, 93, 101, 107, 117, 119, 126, 137, 158 |
| 18F-FDG/18F-FDG | 63, 79, 150, 197, 201 |
| 18F-FDOPA/18F-FDOPA | 69 |
| 18F-flourodeoxyglucose positron emission tomography/ | |
| computerized tomography/18F-florodeoksiglikoz pozitron | |
| emisyon tomografi/bilgisayarlı tomografi | 122 |
| 18fluoride-fluorodeoxyglucose/18florür-florodeoksiglukoz | 129 |
| 6-minute walk distance/6 dakikalık yürüme testi | 28 |
| 68Ga-DOTA-TATE/68Ga-DOTA-TATE | 39 |
| 68Ga-DOTATATE PET/MRI/68Ga-DOTATATE PET/MRG | 107 |
| 68Ga-FAPI/68Ga-FAPI | 201 |
| 68Ga-PSMA/68Ga-PSMA | 63, 79 |
| 68Ge/68Ga generator/68Ge/68Ga jeneratör | 34 |
| Abscess/Apse | 60 |
| Abscessualized cancer/Apseli kanser | 60 |
| AFP/AFP | 79 |
| Artifact/Artefakt | 54 |
| Atypical pulmonary carcinoid tumor/Atipik pulmoner | |
| karsinoid tümör | 101 |
| Benign bone lesions/İyi Huylu kemik lezyonları | 113 |
| Bisphosphonate/Bisfosfonat | 122 |
| Bone scan/Kemik sintigrafisi | 122 |
| Bone SPECT/CT/Kemik SPECT/BT | 187 |
| BRCA1-2 mutation/BRCA1-2 mutasyonu | 158 |
| Breast cancer/Meme kanseri | 129, 158, 201 |
| Breast carcinoma/Meme karsinomu | 117 |
| Breast/Meme | 54 |
| Cancer of the head and neck/Baş boyun kanseri | 177 |
| CEUS/CEUS | 1 |
| Chemical impurity/Kimyasal safsızlık | 34 |
| Childhood malignancy/Çocukluk çağı maligniteleri | 18 |
| Childhood/Çocukluk çağı | 119 |
| Chronic thromboembolic pulmonary hypertension/Kronik | |
| tromboembolik pulmoner hipertansiyon | 28 |
| Colorectal cancer/Kolorektal kanser | 93 |
| Congenital melanocytic nevus/Kongenital melanositik nevüs | 119 |
| Contrast-enhanced echocardiography/Kontrastlı | |
| ekokardiyografi | 67 |
| Coronary angiography/Koroner anjiyografi | 169 |
| COVID-19/ COVID-19 | 197 |
| Cutaneous melanoma/Kutanöz melanoma | 119 |
| Diffusion/Difüzyon | 177 |
| Early Parkinson’s disease detection/Erken Parkinson hastalığı | |
| tespiti | 69 |
| Fluorodeoxyglucose 18F/Florodeoksiglukoz 18F | 110 |
| FUO/FUO | 60 |
| Gallium-68/Galyum-68 | 34 |
| Gastric cancer/Mide kanseri | 150 |
| Gastric carcinoma/Mide kanseri | 63 |
| Gastric metastasis/Mide metastazı | 47 |
| Gastrointestinal hemorrhage/Gastrointestinal kanama | 8 |
| GCA/DHA | 57 |
| GMP/GMP | 34 |
| Hematogical toxicity/Hematolojik toksisite | 193 |
| Hepatobiliary scan/Hepatobiliyer tarama | 54 |
| Hepatocellular cancer/Hepatosellüler kanser | 79 |
| Hepatopulmonary syndrome/Hepatopulmoner sendrom | 67 |
| HER-2/HER-2 | 150 |
| Hybrid imaging/Hibrit görüntüleme | 60 |
| Hypoxia-inducible factor-1α/Hipoksi ile indüklenebilir | |
| faktör-1α | 93 |
| Incidental thyroid nodules/Tesadüfi tiroid nodülleri | 86 |
| Langerhans’ cell histiocytosis/Langerhans hücreli histiyositoz | 187 |
| Lean body mass/Yağsız vücut kütlesi | 144 |
| Li-Fraumeni syndrome/Li-Fraumeni sendromu | 110 |
| Liver/Karaciğer | 54 |
| Long bone/Uzun kemik | 122 |
| lung perfusion scintigraphy/akciğer perfüzyon sintigrafisi | 67 |
| Magnetic resonance imaging/Manyetik rezonans | |
| görüntüleme | 122 |
| mCRPC/mCRPC | 193 |
| Mean pulmonary arterial pressure/Ortalama pulmoner arter | |
| basıncı | 28 |
| Melena/Melena | 47 |
| Metabolic tumor volume/Metabolik tümör hacmi | 86, 129 |
| Metastasis/Metastaz | 117 |
| Metastatic liver lesions/Metastatik karaciğer lezyonları | 1 |
| MTV/MTV | 93 |
| Myocardial perfusion imaging/Miyokard perfüzyon | |
| görüntüleme | 169 |
| Myocarditis/Miyokardit | 50 |
| NaF/NaF | 113 |
| Neuroendocrine tumor/Nöroendokrin tümör | 107 |
| Neuroendocrine tumors/Nöroendokrin tümörler | 39 |
| Normal subjects/Normal olgular | 39 |
| Osteonecrosis/Osteonekroz | 122 |
| Permeability/Permeabilite | 177 |
| PET/CT/PET/BT | 1, 39, 63, 79, 150, 197, 201 |
| Pharmacokinetic model/Farmakokinetik model | 69 |
| Polycythemia vera/Polisitemia vera | 193 |
| Positron emission tomography/computed tomography/ | |
| Pozitron emisyon tomografisi/bilgisayarlı tomografi | 129 |
| Positron emission tomography/Pozitron emisyon | |
| tomografisi | 110, 177 |
| Primary liver tumors/Primer karaciğer tümörleri | 1 |
| Prostate cancer/Prostat kanseri | 193 |
| Prostate carcinoma/Prostat kanseri | 63 |
| Prostate specific membrane antigen/Prostat spesifik | |
| membran antijeni | 144 |
| PRRT/PRRT | 107 |
| PSMA PET/PSMA PET | 57 |
| Pulmonary carcinoid tumor/Pulmoner karsinoid tümör | 101 |
| Pulmonary hamartoma/Pulmoner hamartom | 101 |
| Pulmonary vascular resistance/Pulmoner vasküler direnç | 28 |
| Quantitative analysis/Kantitatif analiz | 69 |
| Radiofrequency ablation/Radyofrekans ablasyon | 1 |
| Radium-223/Radyum-223 | 193 |
| Red blood cell scintigraphy/İşaretli eritrosit sintigrafisi | 8 |
| Response/Tedaviye yanıt | 18 |
| Restaging/Yeniden evreleme | 18 |
| Right-to-left shunt/Sağdan sola şant | 67 |
| SARS-CoV-2/SARS-CoV-2 | 197 |
| Single photon emission computed tomography/computed | |
| tomography/Tek foton emisyonlu bilgisayarlı tomografi/ | |
| bilgisayarlı tomografi | 8 |
| Small-angle Compton scatter/Küçük açılı Compton scatter | 54 |
| Sodium-fluoride PET/Sodyum-florür PET | 113 |
| Somatostatin receptor scintigraphy/Somatostatin reseptör | |
| sintigrafisi | 50 |
| Somatostatin receptors/Somatostatin reseptörleri | 39 |
| SPECT/CT/SPECT/BT | 60, 169 |
| SPECT/SPECT | 50 |
| Squamous cell carcinoma/Yassı hücreli kanser | 177 |
| Staging/Evreleme | 18 |
| Statistical parametric mapping/İstatistiksel parametrik | |
| haritalama | 69 |
| Striped muscle/Çizgili kas | 117 |
| SUL/SUL | 144 |
| SUV/SUV | 144 |
| SUVmax/SUVmaks | 137, 158 |
| Systemic sarcoidosis/Sistemik sarkoidoz | 126 |
| Tc-99m octreotide/Tc-99m oktreotid | 50 |
| Tc-99m-HMPAO-labeled leukocytes/Tc-99m-HMPAO işaretli | |
| lökositler | 60 |
| Technetium-99m-macroaggregated albumin/ | |
| Teknetyum-99m-makrokümelenmiş albümin | 67 |